Horizon Therapeutics Public Ltd Co
HZNPDelisted Oct 6, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492426
Horizon Therapeutics Public Ltd Co was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Oct 6, 2023; 483 institutions reported holding it in 13F filings for Q3 2023, worth $24.8B in total; Soros Fund Management was the only superinvestor holding it.
Holders of 5% or more of HZNP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Horizon Therapeutics Public Ltd Co, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Horizon Therapeutics Public Ltd Co on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Horizon Therapeutics Public Ltd Co, newest first.
No Schedule 13D or 13G filings on Horizon Therapeutics Public Ltd Co are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Horizon Therapeutics Public Ltd Co shares.
No Form 144 notices for Horizon Therapeutics Public Ltd Co are on file.